Abstracts tagged "Chronic pain and PROMIS"

Abstract Number: 261 • 2014 ACR/ARHP Annual Meeting
Validation of the Dutch-Flemish Promis Pain Behavior and Pain Interference Item Banks in Patients with Chronic Pain
Martine Crins¹, Leo D. Roorda², Niels Smits³, Henrica de Vet⁴, Rene Westhovens⁵, David Cella⁶, Karon Cook⁷, Dennis Revicki⁸, Jaap van Leeuwen⁹, Maarten Boers⁴, Joost Dekker¹⁰ and Caroline Terwee⁴, ¹Amsterdam Rehabilitation Research Center | Reade, Amsterdam, Netherlands, ²Amsterdam Rehabilitation Research Center | Reade, Amsterdam, the Netherlands, Amsterdam, Netherlands, ³VU University Medical Center EMGO Institute for Health and Care Research, Department of Epidemiology and Biostatistics, Amsterdam, Netherlands, ⁴Dep of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands, ⁵University of Leuven, Skeletal Biology and Engineering Research Center, Department of Development and Regeneration; Rheumatology, University Hospital Leuven, Leuven, Belgium, ⁶Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁷Center for Patient-Centered Outcomes - Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁸Outcomes Research, United BioSource Corporation, Bethesda, MD, ⁹CEO Leones Group BV, Amsterdam, Netherlands, ¹⁰Rehabilitation Medicine, VU University Medical Center, Amsterdam, Netherlands
Background/Purpose: In the assessment of chronic pain patients it is important to measure pain behavior and pain interference. The National Institutes of Health’s Patient-Reported Outcomes…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].